L3 - VIRUS-CELL & CORONA Flashcards

1
Q

Viruses only infect a subset of cells in host organism’s bodies (cells that express the viral receptor). Those cells can either be:

A
  1. Permissive: allow for viral infection and production of viral progenies (cause productive infection)
    * Lead to cytopathic effects (observable effects that cause changes in the host cell ex. cell lysis)
    * Permissive infection can be:
    o An acute infection (usually by RNA viruses) – which either results in cell death due to production and release of viral progenies or cell survival by clearing of viruses
    o A persistent infection (usually by large dsDNA viruses) – cell survives from infection but still contains the virus. Persistent infection can be:
     Latent: the cell survives with the virus is still inside the cell but is not producing viral proteins or viral progenies. The virus just remains in the host for a long period of time and cannot be rid of (ex. herpes)
     Chronic: the cell survives with the virus inside the cell producing viral progenies at low level over a long period of time
  2. Non-permissive: only allows for viral infection but do not produce viral progenies
    * Lead to abortive or restrictive infection (host cell produces proteins to defend against the viral infection vigorously)
  • Some cells can switch between permissive and non-permissive states
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cancer from viral infection:

A

Both permissive and non-permissive cells can lead to cancer by causing cell transformation.
* Viral infection of permissive cells can lead to oncogenesis – virus cause turn on of oncogene, turn off of tumor suppressor gene, or the virus itself can contain a viral oncogene.
* Abortive & restrictive infection of non-permissive cells can also cause cell transformation, giving rise to cancer.
* Ex. SV40 causing abortive infection & cancer in mice, human papilloma virus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Viral effects on host cells:

A
  1. Morphological effects
  2. Effects on cell biochemistry and physiology
  3. genetics
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q
  1. Morphological effects
A
  • Changes to morphology of the cell (how the cell looks like under light microscope)
  • Occurs due to accumulation of viral particles being produced, forming inclusion bodies
  • Inclusion bodies are formed in different parts of the cell depending on where the virus associates, causing morphological changes to those organelles/parts of the cell.
    o Includes: cytoplasm, nucleus, microtubules – some virus uses the microtubule network to move around so inclusion bodies form bends and change the microtubule network
  • Envelope virus can cause syncytia formation (giant multinucleated cells)
    o Host cell infected by envelope virus will produce and traffic viral envelope proteins to surface of the cell
    o These envelope proteins mediate fusion events between virus and host cells, but also between infected and uninfected cells
    o this cause multinucleated syncytial cell – a process co-opted by humans for placenta formation (placenta cells are multinucleated - syncytins). Without co-option with envelope virus, placental mammals cannot occur.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
  1. Effects on cell biochemistry and physiology
A
  • During a virus life cycle, it will induce production of different proteins in waves
  • function of those proteins is to interact and take over the host cell to prepare it for viral progeny production
  • The waves of proteins produced are to cause stages of:
    1. activation of cellular protein kinases & transcription factors
    2. activation of cellular oncogenes, cell cycle arrest
    3. inhibition of DNA synthesis
  • Ex. Cytomegalovirus (large dsDNA virus)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q
  1. Genetic effects
A
  • Usually caused by DNA viruses because they replicate in the nucleus (closely associated with DNA replication)
  • Can be due to:
    o Virus stops cell from entering S phase – viruses encode for genes that cause cell cycle arrest by knocking down retinoblastoma or p53
     The virus wants the cell to prepare for replication to replicate the viral genome, but not the host cell’s own genome
     If the cell is paused at a stage for long = can cause damage to DNA
    o A lot of viral replications happening inside nucleus can cause chromosomal damage, such as exchanged chromatids and mutations
    o Abortive infection – cause a lot of chromosomal damage so cells are transformed (ex. SV40 in mouse cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Host cellular defenses against viral infection

A

Cells can be induced to defend against viral infection OR innately contain non-induced defenses such as constant low-level production of antiviral defense proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Induced defenses:

A
  • Infected cells release interferons in response to viral infection
  • Interferons will travel and bind to uninfected cells to warn them that viruses are present in the host and prime them by turning on antiviral defense mechanisms
  • Uninfected cells are then induced to produce antiviral defense proteins that target many different stages of the viral life cycle
    1. Transcription inhibitors
    2. Translation inhibitors
    3. Protein processing inhibitors
    4. Virus maturation inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

induced antiviral defense proteins

A

Cells do no produce inhibitors that target only 1 stage of the viral lifecycle because targeting of different stages can allow the virus to become less likely to develop resistance
* Ex. combination therapy used to combat HIV infection – utilize integrase, polymerase, protease inhibitors, all at the same time

These induced antiviral defense proteins are not always produced because they require a lot of energy and can slow down the efficiency of the host cellular mechanism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Examples of antiviral defense proteins:

A

Translation inhibitory protein (TIP)

TRIM5 protein

Tetherin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Translation inhibitory protein (TIP)

A

usually for defense against RNA viruses
* Interferon binding to uninfected cell triggers pathway that sends a signal to host cell chromosome to express TIP
* Once translated, TIP binds to ribosome & modifies the ribosome to be more particular about the RNA it is able to translate – the TIP modified ribosome will check more closely for the correct caps and structure of RNA
* Usually, viral RNA does not have the correct cap and is not the exact same as the host mRNA
* Therefore, TIP modified ribosome will not be able to translate the viral RNA and the ribosome efficiency will also slow down, translating mRNA more slowly (reason why it’s not always turned on in the host cell)

Interferon release and binding ensures that other uninfected cells in the host organism is primed with modified ribosome to defend against viral infection

However, Influenza uses TIP against the host cell
* Influenza RNA does not have a cap. Upon infection, it steals the cap of the host mRNA.
* Therefore, TIP modified ribosome will both be able to translate the viral RNA while also rejecting host RNA as foreign

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

TRIM5 protein

A

– in cytoplasm
* acts against uncoating of viruses by binding to capsid protein so viral DNA can’t be released into cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tetherin

A

– for defense against enveloped viruses (ex. HIV, Ebola, SARS-COV-2)
* Acts as a pair
* Has transmembrane region at 1 end and a GPI anchor at another end, thus can cross-link 2 membranes together (host cell membrane and viral cell membrane)
* So can prevents viral escape
* Viruses can also have a counter defense against host defense mechanism by encoding for proteins that degrade host cell antiviral defense proteins
Ex: viral counter defense against Tetherin
* HIV1 encodes for VPU gene that degrades Tetherin
Or viral machinery that prevents cell from undergoing apoptosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Non-induced defenses:

A
  • Antiviral defense proteins constantly expressed at low levels in cells

Ex: APOBEC3G gene which defends against retroviruses
* APOBEC3G gets packaged with the virus as the viral particle assembles and leaves the host cell
* As the virus infects another cell, it also releases APOBEC3G into the cell
* APOBEC3G will deaminate the viral genome during reverse transcription, causing C to U mutation in the minus strand which results in G to A mutation in the proviral DNA
* This will cause degradation of the hypermutated viral genome or result in hypermutation in the viral progeny which might cause it to not be virulent anymore

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Viral counter defense:

A

acquisition of the viral infectivity factor (vif) gene which shunts the APOBEC3G into a degradation pathway

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cellular transformation by retroviruses ex. HIV

A

contain oncogene (transforming viruses)
* generated when cellular protooncogene is inserted into the viral genome during viral replication
* the cellular oncogene is not captured as a whole sequence. Some part of the sequence is not inserted, which is the part responsible for turning off, regulating the oncogene activity
o Therefore, the oncogene activity from the transforming virus can’t be turned off by host cell, causing cellular transformation
* ex. RSV – contain src, an oncogene, expresses protein-tyrosine kinase
o overexpression of src can cause cell proliferation and transformation, thus leading to cancer

o a virus related to RSV, ALV, contain the same genes except the oncogene
 therefore, RSV can cause cellular transformation upon infection while ALV does not

17
Q

by DNA viruses

A

ex. human papilloma virus (HPV)
* has a capsid but no envelope
* contain eight ORFs, with some overlap
* infect basal cells in the cervix
* in normal conditions, does not cause cervical cancer
o upon infection, virus migrates with the infected basal cell as it migrates to the surface of the cervix to develop into epithelial cells
o the migration can take weeks, so during that time, the viral genome continues replicates so there is more expression of the viral gene as the cell gets closer to the surface
o viral genome is organized in episomes – a special type of plasmid, a circular DNA, that replicate independently of the host cell
o This can cause benign growth or wart

  • However, there can be accidental integration of a proportion of the viral episome into host genome
    o the portion contains E6 and E7 gene which downregulates Rb1 and p53, genes involved in cell cycle arrest and apoptosis
    o E6 and E7 are always expressed in the infected cells but are under tight control of other viral proteins. Accidental integration of E6 and E7 into host genome causes unconstrained expression of E6 and E7 gene, resulting in host cell transformation and cervical cancer
18
Q

Coronaviruses Morphology

A
  • Enveloped +sense ssRNA virus
  • Contains 2 or more envelop proteins: ex. spike glycoproteins
  • Slightly ‘odd’ shaped core with a nucleoprotein surrounding the RNA, often in a helical arrangement
  • Virion particle does not contain a polymerase, but is encoded in the genome
19
Q

coronaviruses Taxonomy + Phylogenies

A
  • A subset of the nidovirales: nested subgenomic 3’ RNAs
  • mostly interested in subfamily coronavinae which contains alpha, beta, gamma, delta virus genera (mainly interested in beta CoVs)
  • Infect mammalian, avian, bats hosts – has plasticity in host infection: can infect many species (have many animal reservoirs)
  • Bats are common reservoir host for humans and likely to have another intermediate host
    o Ex. SARS1 = bats to civet to humans, MERS = bats to camel to humans
  • not all pathogenic - less than half human coronaviruses are pathogenic, they typically just cause mild cold
20
Q

coronavirus Genomic organization

A
  • genomes are much bigger than other RNA viruses – encode for a separate protein with proofreading activity
    o certain drugs are developed to bind to the proofreading protein and inhibit it to induce hypermutation in the viral progeny so it might not survive
  • encode for:
    o viral polymerase complex for viral genome replication
    o spike proteins & other envelope proteins
    o proteins involved in preventing interferon expression
21
Q

coronavirus Life cycle

A
  • binds to receptor
  • enters via endosome
  • lyses endosome
  • undergoes replication in cytoplasm
  • envelope protein produced by ER and get sub surface assembly
  • released by exocytosis

Whether a viral infection becomes a pandemic or not is just luck – depends on presence of certain host restriction factors, interaction between the reservoir species and intermediate host, etc.

22
Q

MERS-CoV

A
  • seasonal – yearly outbreak
  • reproductive number <1 – not a lot of human-human transmission
  • found in middle east – bats carry virus & transmit to camels (intermediate host) then to humans
  • high mortality rate – 35%
23
Q

SARS-CoV

A
  • transmitted via airborne droplets
  • reproductive number of 2-5 –increasing over time (start from about 3 to now nearly 20 in omicron variants)
  • 10% mortality
  • Transmitted from bats (reservoir species) to civets (intermediate host) to humans
  • Causes injury to lungs and dissemination to other organs
  • Cause flu-like symptoms, fever, chills, shortness of breath, persistent fever (symptoms have been changing with the evolution of new variants)
24
Q

SARS-CoV-2 spike mutations

A
  • Low rate of mutation due to proofreading activity but high replication still causes mutations + long term infections in humans can further promote mutations
  • Mutations give rise to novel forms of spike-like proteins (even minor mutations in residues involved in binding to ACE2 receptor can change SARS-CoV-2 host affinity which allows for plasticity and infection of many various organisms)
  • Reproductive number can change over time within the same variant – depending on seasons, countries, population density, etc. ex. higher in winter than summer
25
Q

The future of SARS-CoV-2

A
  • New variants will continually arise, causing near extinction of the previous variants
  • Vaccines should offer some cross protection to these variants ex. bivalent vaccines – Pfizer that protect against original virus + omicron
  • Might evolve to be less pathogenic overtime & host can become better at defending against the virus